| Literature DB >> 35682698 |
Priyanka Reddy1, Tim Plozza1, Vilnis Ezernieks1, Dario Stefanelli2, Alessio Scalisi3, Ian Goodwin3,4, Simone Rochfort1,5.
Abstract
The triggers of biennial bearing are thought to coincide with embryonic development in apple and occurs within the first 70 days after full bloom (DAFB). Strong evidence suggests hormonal signals are perceived by vegetative apple spur buds to induce flowering. The hormonal response is typically referred to as the floral induction (FI) phase in bud meristem development. To determine the metabolic pathways activated in FI, young trees of the biennial bearing cultivar 'Nicoter' and the less susceptible cultivar 'Rosy Glow' were forced into an alternate cropping cycle over five years and an inverse relationship of crop load and return bloom was established. Buds were collected over a four-week duration within 70 DAFB from trees that had maintained a four-year biennial bearing cycle. Metabolomics profiling was undertaken to determine the differentially expressed pathways and key signalling molecules associated with biennial bearing. Marked metabolic differences were observed in trees with high and low crop load treatments. Significant effects were detected in members of the phenylpropanoid pathway comprising hydroxycinnamates, salicylates, salicylic acid biosynthetic pathway intermediates and flavanols. This study identifies plant hormones associated with FI in apples using functional metabolomics analysis.Entities:
Keywords: Malus domestica Borkh; apple bud; biennial bearing; chemical signalling; metabolomics; plant hormones; return bloom
Mesh:
Substances:
Year: 2022 PMID: 35682698 PMCID: PMC9181029 DOI: 10.3390/ijms23116019
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Flower clusters counted on trees in the 2019/2020 season against the crop loads (fruit/cm2 tree’s trunk cross sectional area (TCSA)) of those trees in the 2018/2019 season for: (A) ‘Nicoter’; (B) ‘Rosy Glow’. Each point is the average of three trees with standard error bars.
Figure 2Principal component analysis (PCA) score plot showing ‘Nicoter’ (n = 35) and ‘Rosy Glow’ (n = 33) apple spur bud extracts evaluated on (A) ESI+ UHPLC-HRMS and (B) ESI- UHPLC-HRMS with a pooled biological quality control (PBQC) and categorised by (A1,B1) variety and (A2,B2) collection date.
Figure 3Orthogonal partial least squares discriminant analysis (OPLS-DA) of NVLOW and NVHIGH extracts acquired in UHPLC-HRMS. NVLOW (+) and NV HIGH (Δ) OPLS-DA score plot for (A) ESI+ mode with an associated 95% confidence ellipses (Q2 = 0.601, R2Y = 0.724) and (B) ESI- mode with an associated 95% confidence ellipses (Q2 = 0.568, R2Y = 0.709). Both models were significant indicated by 100 different model permutations for (A) (p < 0.01, Q2 = 0.807 and R2Y = 0.983) and (B) (p < 0.01, Q2 = 0.816 and R2Y = 0.934).
Metabolites identified in UHPLC-HRMS ESI+ data that were significant (VIP > 1.5) in the OPLSDA model between NVHIGH compared to NVLOW apple spur buds with associated effect size. Benjamini–Hochberg adjusted p values (Q-values) indicate those metabolites that are significant in the linear model with the (y ~ return bloom) for NVLOW, NVMID and NVHIGH.
| Identity | Retention Time (min) | Mass (m/z) [M + H] + | Molecular Formula | Mass | VIP Score | Effect Size | * | Q-Value (BH | MS2 Ions | Metabolite Level |
|---|---|---|---|---|---|---|---|---|---|---|
| chlorogenic acid | 3.68 | 355.1019 | C16H18O9 | −1.41 | 2.5 | 2.1 | ↑ | 1.4 × 10−6 | 163.0390, 145.0287, 135.0443, 117.0339 | 2 |
| hydroxycoumarin | 3.68 | 163.0389 | C9H6O3 | −0.43 | 2.5 | 2.0 | ↑ | 1.4 × 10−6 | 135.0442, 107.0495, 95.0498, 79.0391 | 2 |
| coumaranone | 3.68 | 135.0440 | C8H6O2 | −0.41 | 2.5 | 2.0 | ↑ | 1.5 × 10−6 | 117.0339, 107.0491, 89.0386 | 2 |
| chlorogenic acid derivative I | 3.67 | 728.1708 | - | - | 2.3 | 2.0 | ↑ | 8.9 × 10−5 | 374.0763, 551.1243, 747.1460, 163.0393, | 4 |
| chlorogenic acid derivative II | 3.67 | 559.1093 | - | - | 2.3 | 1.9 | ↑ | 2.5 × 10−5 | 188.0710, 163.0394, 145.0287, 135.0444 | 4 |
| chlorogenic acid derivative III | 3.67 | 382.0613 | - | - | 2.3 | 1.7 | ↑ | 2.0 × 10−5 | 163.0393, 135.0446, 89.0392 | 4 |
| chlorogenic acid derivative IV | 3.71 | 645.1810 | - | - | 2.3 | 2.5 | ↑ | 2.5 × 10−4 | 291.0858, 163.0392, 139.0393 | 4 |
| hydroxibenzoisochromanquinone derivative | 4.15 | 230.0572 | C13H9O4 | −0.70 | 2.2 | 1.4 | ↑ | 9.3 × 10−5 | 147.0442, 119.0495, 91.0545 | 3 |
| chlorogenic acid derivative V | 3.68 | 551.1230 | - | - | 2.2 | 1.7 | ↑ | 1.3 × 10−4 | 163.0394, 145.0289, 135.0445, 117.0339, 89.0391 | 4 |
| afzelechin 7-apioside | 5.59 | 407.1336 | C20H22O9 | −0.14 | 2.1 | 1.3 | ↑ | 4.1 × 10−3 | 257.0814, 205.0495, 181.0498, 107.0497 | 2 |
| chlorogenic acid derivative VI | 3.68 | 217.5414 | - | 2.1 | 1.8 | 1.6 × 10−4 | 163.0392, 135.0442, 117.0337, 89.0388 | 4 | ||
| 3-O-acetyl-2-O-coumaroyl-hexopyranose | 4.66 | 369.1180 | C17H20O9 | −0.02 | 2.1 | 1.6 | ↓ | 9.0 × 10−3 | 119.0494, 91.0547, 85.0289 | 2 |
| (R)-shinanolone | 4.66 | 193.0860 | C11H12O3 | 0.40 | 2.0 | 1.5 | ↓ | 6.3 × 10−3 | 193.0861, 91.0546, 57.0340 | 2 |
| 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-5-yl β-D-glucopyranoside | 5.43 | 435.1284 | C21H22O10 | −0.39 | 1.8 | 1.3 | ↑ | 1.7 × 10−2 | 271.0615, 151.0028, 119.0493, 107.0128 | 2 |
| 1-O-feruloylglucose | 4.19 | 357.1176 | C16H20O9 | −1.14 | 1.7 | 1.6 | ↓ | 3.5 × 10−2 | 177.0546, 147.0443, 137.0598, 119.0495 | 2 |
| 3,4 dihydroxybenzaldehyde | 4.04 | 139.0389 | C7H6O3 | −0.51 | 1.7 | 1.2 | ↑ | 3.4 × 10−2 | 111.0444, 93.0339, 83.0496 | 2 |
| naringenin | 5.43 | 273.0757 | C15H12O5 | −0.18 | 1.6 | 1.3 | ↑ | 3.6 × 10−2 | 231.0662, 153.0184, 147.0443, 119.0495 | 2 |
| kaempferol-3-O-α-L-rhamnopyranoside | 5.30 | 433.1125 | C21H20O10 | −0.98 | 1.6 | 1.3 | ↑ | 1.1 × 10−2 | 287.0556, 271.0603, 85.0289, 71.0497 | 2 |
| kaempferol | 5.24 | 287.0547 | C15H10O6 | −1.10 | 1.6 | 1.3 | ↑ | 2.9 × 10−2 | 213.0549, 153.0182, 121.0284 | 2 |
| salicylaldehyde | 4.04 | 123.0440 | C7H6O2 | −0.46 | 1.6 | 1.2 | ↑ | 4.8 × 10−2 | 95.0496, 77.0391, 67.0547, 53.0381 | 2 |
* ↑ = up-regulated in NVHIGH, ↓ = down-regulated in NVHIGH.
Metabolites identified in UHPLC-HRMS ESI- data that were significant (VIP > 1.5) in the OPLSDA model between NVHIGH compared to NVLOW apple spur buds with associated effect size. Benjamini–Hochberg adjusted p values (Q-values) indicate those metabolites that are significant in the linear model with the (y ~ return bloom) for NVLOW, NVMID and NVHIGH.
| Identity | Retention Time (min) | Mass (m/z) [M − H] − | Molecular Formula | Mass | VIP Score | Effect Size | * | Q-Value (BH | MS2 Ions | Metabolite Level |
|---|---|---|---|---|---|---|---|---|---|---|
| quinic acid | 3.68 | 191.0556 | C7H12O6 | −2.68 | 2.4 | 2.4 | ↑ | 1.4 × 10−8 | 191.0556, 173.0449, 127.0391, 82.0284 | 2 |
| chlorogenic acid | 3.68 | 353.0882 | C16H18O9 | 1.12 | 2.3 | 2.4 | ↑ | 4.8 × 10−8 | 191.0556, 353.0886, 173.0450 | 2 |
| 4-acetyl-3-hydroxy-5-methylphenyl β-D-glucopyranoside | 3.52 | 327.1092 | C15H20O8 | 2.02 | 2.2 | 1.8 | ↑ | 8.3 × 10−7 | 165.0548, 147.0449, 163.0392, 121.0646, 119.0493 | 2 |
| chlorogenic acid derivative VII | 3.71 | 643.1680 | - | - | 2.2 | 2.8 | ↑ | 7.7 × 10−6 | 191.0567, 353.0878 | 4 |
| quinic acid isomer | 4.15 | 191.0556 | C7H12O6 | −2.68 | 2.2 | 2.1 | ↑ | 6.8 × 10−6 | 191.0556, 173.0449, 127.0391, 82.0284 | 2 |
| Methyl salicylate glycoside derivative | 4.33 | 461.1670 | C20H30O12 | 1.19 | 2.1 | 1.8 | ↓ | 6.1 × 10−4 | 191.0555, 251.0773, 149.0455, 131.0340, 415.1611 | 2 |
* ↑ = up-regulated in NVHIGH, ↓ = down-regulated in NVHIGH.
Figure 4Orthogonal partial least squares discriminant analysis (OPLS-DA) of RVLOW and RVHIGH extracts acquired in UHPLC-HRMS. RVLOW (+) and RVHIGH (Δ) OPLS-DA score plot of (A) ESI+ mode with an associated 95% confidence ellipses (Q2 = 0.231, R2Y = 0.647) and (B) ESI- mode with an associated 95% confidence ellipses (Q2 = 0.071, R2Y = 0.593). Both models were significant indicated by 100 different model permutations for (A) (p < 0.01, Q2 = 0.757 and R2Y = 0.985) and (B) (p < 0.01, Q2 = 0.785 and R2Y = 0.983).
Metabolites identified in UHPLC-HRMS ESI+ data that were significant (VIP > 1.5) in the OPLSDA model between RVHIGH compared to RVLOW apple spur buds with associated effect size. p values indicate those metabolites that are significant in the linear model with the (y ~ returnbloom) for RVLOW, RVMID and RVHIGH.
| Identity | Retention Time (min) | Mass (m/z) [M + H] + | Molecular Formula | Mass Error (ppm) | VIP Score | Effect Size | * | MS2 Ions | Metabolite Level | |
|---|---|---|---|---|---|---|---|---|---|---|
| D-(-)-mannitol | 1.23 | 183.0862 | C6H14O6 | −0.65 | 2.3 | 1.3 | ↑ | 5.2 × 10−3 | 181.0712, 101.0239, 89.02338, 71.0128 | 2 |
| chlorogenic acid derivative VIII | 3.68 | 775.1544 | - | 2.2 | 1.2 | ↑ | 4.5 × 10−1 | 709.0716, 532.0876, 421.0622, 163.0393 | 4 | |
| chlorogenic derivative IX | 3.68 | 551.1230 | - | 1.9 | 1.6 | ↑ | 5.9 × 10−2 | 585.1142, 374.0770, 255.0183, 163.0394 | 4 | |
| kaempferol | 5.24 | 287.0547 | C15H10O6 | −1.09 | 1.9 | 1.3 | ↑ | 2.9 × 10−2 | 213.0549, 153.0182, 121.0284 | 2 |
| 3-caffeoyl-1,5-quinolactone | 4.17 | 337.0915 | C16H16O8 | −0.87 | 1.8 | 1.5 | ↑ | 3.2 × 10−3 | 163.0411, 145.0304, 135.0460, 117.0351 | 2 |
| chlorogenic derivative X | 3.67 | 728.1708 | - | 1.8 | 1.5 | ↑ | 2.8 × 10−1 | 551.1243, 374.0763, 163.0393 | 4 | |
| chlorogenic acid | 3.68 | 355.1019 | C16H18O9 | −1.29 | 1.6 | 1.4 | ↑ | 1.3 × 10−1 | 163.0390, 145.0287, 135.0443, 117.0339 | 2 |
| hydroxycoumarin | 3.68 | 163.0389 | C9H6O3 | −0.43 | 1.6 | 1.3 | ↑ | 1.1 × 10−1 | 135.0442, 107.0495, 95.0498, 79.0391 | 2 |
| coumaranone | 3.68 | 135.0440 | C8H6O2 | −0.41 | 1.5 | 1.3 | ↑ | 1.4 × 10−1 | 117.0339, 107.0491, 89.0386 | 2 |
* ↑ = up-regulated in RVHIGH ↓ = down-regulated in RVHIGH.
Metabolites identified in UHPLC-HRMS ESI- data that were significant (VIP > 1.5) in the OPLSDA model between RVHIGH compared to RVLOW apple spur buds with associated effect size. p values indicate those metabolites that are significant in the linear model with the (y ~ returnbloom) for RVLOW, RVMID and RVHIGH.
| Identity | Retention Time (min) | Mass (m/z) [M − H] − | Molecular Formula | Mass Error (ppm) | VIP Score | Effect Size | * | MS2 Ions | Metabolite Level | |
|---|---|---|---|---|---|---|---|---|---|---|
| L-histidine | 1.14 | 154.0613 | C6H9N3O2 | −5.84 | 3.1 | 2.8 | ↓ | 1.7 × 10−3 | 154.0614, 137.0348, 93.0448, 80.0691 | 2 |
| L-aspartate | 1.20 | 132.0292 | C4H7NO4 | −7.81 | 2.0 | 1.3 | ↓ | 5.5 × 10−2 | - | 3 |
| aspartyl-histidine | 1.21 | 269.0881 | C10H14N4O5 | −3.88 | 2.7 | 1.3 | ↑ | 2.1 × 10−3 | - | 3 |
| 2,5-dihydroxybenzoic acid 2-O-β-D-glucoside | 2.96 | 315.0730 | C13H16O9 | 2.70 | 1.8 | 1.4 | ↑ | 3.2 × 10−2 | - | 3 |
| dihydro-trans-o-coumaric acid 2-glucoside | 3.52 | 327.1092 | C15H20O8 | 2.02 | 2.2 | 1.2 | ↑ | 2.6 × 10−2 | 181.0714, 165.0550, 145.0287, 119.0494 | 2 |
| quinic acid | 3.68 | 191.0556 | C7H12O6 | −2.68 | 1.5 | 1.4 | ↑ | 1.1 × 10−1 | 191.0556, 173.0449, 127.0391, 82.0284 | 2 |
| chlorogenic acid | 3.68 | 353.0882 | C16H18O9 | 1.12 | 1.8 | 1.4 | ↑ | 7.9 × 10−2 | 191.0556, 353.0886, 173.0450 | 2 |
| phlorisobutanophenone glycoside | 3.70 | 357.1193 | C16H22O9 | 0.54 | 2.0 | 1.2 | ↑ | 4.5 × 10−2 | 311.0544, 289.0723, 195.0659 | 2 |
| 1-O-feruloylglucose | 3.97 | 355.1041 | C16H20O9 | 1.82 | 1.6 | 1.4 | ↑ | 9.5 × 10−2 | 177.0546, 147.0443, 137.0598, 119.0495 | 2 |
* ↑ = up-regulated in RVHIGH ↓ = down-regulated in RVHIGH.
Figure 5Compounds associated with the PAL (Phenylalanine Ammonia-Lyase) pathway to salicylic acid, including (A) hydroxycinnamates, (B) salicylates and (C) flavanols, show significant effects in ‘Nicoter’ and ‘Rosy Glow’ variable treatments associated with meristem bud formation.
The molecular formula, accurate mass, [M + H] + and retention time of individual plant hormones and structural derivatives.
| Name | Molecular Formula | Acurate Mass | [M + H] + | Retention Time (min) |
|---|---|---|---|---|
| Methyl (+/−)-jasmonate | C13H20O3 | 224.1412 | 224.1412 | 8.13 |
| Gibberellic acid | C19H22O6 | 346.1416 | 347.1495 | 4.65 |
| Adenine | C5H5N5 | 135.0545 | 136.0623 | 1.32 |
| Adenosine | C10H13N5O4 | 267.0968 | 268.1046 | 1.33 |
| Indole-3-acetonitrile | C10H8N2 | 156.0687 | 157.0766 | 6.65 |
| Indole-3-acetic acid | C10H9NO2 | 175.0633 | 176.0712 | 5.68 |
| 2-oxindole-3-acetic acid | C10H9NO3 | 191.0582 | 192.0661 | 4.42 |
| Tryptophan | C11H12N2O2 | 204.0899 | 205.0977 | 3.51 |
| (+/−)-Abscisic acid | C15H20O4 | 264.1362 | 265.1440 | 5.95 |
| SA | C7H6O3 | 138.0317 | 139.0395 | 5.87 |
| Methyl-indole-3-acetic acid | C11H11NO2 | 189.0790 | 190.0868 | 7.10 |
| Tryptamine | C10H12N2 | 160.1000 | 161.1078 | 3.82 |